Abstract
Surv Anesthesiol 2016;60(2):78–78 Lipid-soluble intravenous anesthetics, of which the current standard is propofol lipid emulsion, can cause infections, contamination, lipid toxicity, and potential respiratory and cardiovascular depression in patients. Subsequently, in this phase 1c, randomized, double-blind, dose-finding, human study, authors examined a potential alternative, Phaxan (PHAX; Chemic Labs, Canton, Mass; aqueous solution of 10-mg/mL alphaxalone and 13% 7-sulfobutyl-ether β-cyclodextrain).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
